M. Arfan Ikram

M. Arfan Ikram, MD, Ph.D. is head of neuroepidemiology in the Rotterdam Study. He has a longstanding interest in epidemiology of brain ageing and dementia, including Alzheimer’s disease.

Throughout his career he has used many state-of-the-art technologies implemented in population-based cohort studies. He has used a wide variety of imaging techniques, including structural MRI, diffusion tensor imaging, phase-contrast angiography and CT-scanning, as well as post-processing algorithms, including (semi-)automatic segmentation, linear and non-linear registration, voxel-based analysis, and tractography, to study various aspects of neurodegenerative disease.

Additionally, he has broad expertise in conventional and emerging genomics technologies, including whole-genome genotyping arrays, exome arrays, and exome sequencing. In recent years, he has published several studies that combine imaging and genetics in the study of neurodegenerative disease. Dr. Ikram has published over 200 peer-reviewed articles and has a H-index of 34. He co-leads several national and international consortia, including neuro-CHARGE, UNIVERSE, JPND HD-READY, Dutch ImaGene